Last quarter (Q3 2022), Sumitomo Dainippon Pharma Co's total revenue was $140.98B, an increase of 1.90% from the same quarter last year. In Q3, Sumitomo Dainippon Pharma Co's net income was $-11.22B. See Sumitomo Dainippon Pharma Co’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Total Revenue	$ 588.23B	$ 555.54B	$ 560.03B	$ 515.95B	$ 482.73B	$ 459.27B
Cost of Revenue	$ 179.06B	$ ―	$ 157.13B	$ 137.77B	$ 129.67B	$ 113.55B
Gross Profit	$ 409.17B	$ ―	$ 402.91B	$ 378.18B	$ 353.06B	$ 345.71B
Operating Expense	$ 424.94B	$ ―	$ 342.67B	$ 306.95B	$ 269.82B	$ 287.83B
Operating Income	$ -15.77B	$ ―	$ 60.23B	$ 71.22B	$ 83.24B	$ 57.88B
Net Non Operating Interest Income Expense	$ 35.34B	$ ―	$ 22.73B	$ 6.63B	$ 708.00M	$ 7.16B
Other Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ 19.57B	$ ―	$ 82.96B	$ 77.85B	$ 83.95B	$ 65.05B
Tax Provision	$ 46.78B	$ ―	$ 42.36B	$ 41.02B	$ 48.03B	$ 16.42B
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -8.45B	$ ―	$ 56.41B	$ 56.22B	$ 40.75B	$ 48.63B
Basic EPS	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted EPS	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Basic Average Shares	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted Average Shares	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 604.00B	$ ―	$ 499.80B	$ 444.73B	$ 399.49B	$ 401.38B
Net Income From Continuing And Discontinued Operation	$ -8.45B	$ ―	$ 56.41B	$ 56.22B	$ 40.75B	$ 48.63B
Normalized Income	$ -8.45B	$ ―	$ 56.41B	$ 56.22B	$ 40.75B	$ 48.63B
Interest Expense	$ 32.49B	$ ―	$ 3.05B	$ 2.59B	$ 2.86B	$ 207.00M
EBIT	$ 52.06B	$ ―	$ 86.01B	$ 80.44B	$ 86.81B	$ 65.25B
EBITDA	$ 94.31B	$ -3.50B	$ 124.36B	$ 103.11B	$ 104.17B	$ 79.23B

Currency in USD

Sumitomo Dainippon Pharma Co Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing